Claret Medical Lands $18,000,000 Series B Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9752c248-3a4c-4f1c-b473-4c92f844c9d0 - Date
8/22/2014 - Company Name
Claret Medical - Mailing Address
1745 Copperhill Parkway Santa Rosa, CA 95403 USA - Company Description
Claret Medical is a company dedicated to the development of interventional products for stroke prevention. - Website
http://www.claretmedical.com - Transaction Type
Venture Equity - Transaction Amount
$18,000,000 - Transaction Round
Series B - Proceeds Purposes
Proceeds will be used primarily to complete the U.S. pivotal trial of the company’s Sentinel™ Cerebral Protection System (CPS) for embolic protection during transcatheter aortic valve replacement (TAVR), which received Investigational Device Exemption (IDE) approval earlier this year. - M&A Terms
- Venture Investor
- Venture Investor
- Venture Investor
